NF-κB and STAT3 – key players in liver inflammation and cancer (original) (raw)

• Dvorak HF . Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315:1650–1659.
  Article CAS PubMed Google Scholar
• Schafer M, Werner S . Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 2008; 9:628–638.
  Article CAS PubMed Google Scholar
• Coussens LM, Werb Z . Inflammation and cancer. Nature 2002; 420:860–867.
  Article CAS PubMed PubMed Central Google Scholar
• Ernst PB, Gold BD . The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 2000; 54:615–640.
  Article CAS PubMed Google Scholar
• Seeff LB . Introduction: The burden of hepatocellular carcinoma. Gastroenterology 2004; 127:S1–S4.
  Article PubMed Google Scholar
• Balkwill F, Mantovani A . Inflammation and cancer: back to Virchow? Lancet 2001; 357:539–545.
  Article CAS PubMed Google Scholar
• Parkin DM, Bray FI, Devesa SS . Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 Suppl 8:S4–66.
  Article CAS PubMed Google Scholar
• Bosch FX, Ribes J, Diaz M, Cleries R . Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127:S5–S16.
  Article PubMed Google Scholar
• Tong MJ, el-Farra NS, Reikes AR, Co RL . Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332:1463–1466.
  Article CAS PubMed Google Scholar
• Nakamoto Y, Kaneko S . Mechanisms of viral hepatitis induced liver injury. Curr Mol Med 2003; 3:537–544.
  Article CAS PubMed Google Scholar
• Herzer K, Sprinzl MF, Galle PR . Hepatitis viruses: live and let die. Liver Int 2007; 27:293–301.
  Article CAS PubMed Google Scholar
• Block TM, Mehta AS, Fimmel CJ, Jordan R . Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003; 22:5093–5107.
  Article CAS PubMed Google Scholar
• Sen R, Baltimore D . Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986; 46:705–716.
  Article CAS PubMed Google Scholar
• Barnes PJ, Karin M . Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336:1066–1071.
  Article CAS PubMed Google Scholar
• Ghosh S, Karin M . Missing pieces in the NF-κB puzzle. Cell 2002; 109 Suppl:S81–S96.
  Article CAS PubMed Google Scholar
• Vallabhapurapu S, Karin M . Regulation and function of NF-κB transcription factors in the immune system. Annu Rev Immunol 2009; 27:693–733.
  Article CAS PubMed Google Scholar
• Gilmore TD . The Re1/NF-κB/I κB signal transduction pathway and cancer. Cancer Treat Res 2003; 115:241–265.
  Article CAS PubMed Google Scholar
• Karin M, Cao Y, Greten FR, Li ZW . NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2:301–310.
  Article CAS PubMed Google Scholar
• Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K, Siebenlist U . The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature 1992; 359:339–342.
  Article CAS PubMed Google Scholar
• Bours V, Franzoso G, Azarenko V, et al. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 1993; 72:729–739.
  Article CAS PubMed Google Scholar
• Annunziata CM, Davis RE, Demchenko Y, et al. Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 2007; 12:115–130.
  Article CAS PubMed PubMed Central Google Scholar
• Keats JJ, Fonseca R, Chesi M, et al. Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma. Cancer Cell 2007; 12:131–144.
  Article CAS PubMed PubMed Central Google Scholar
• Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D . Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995; 376:167–170.
  Article CAS PubMed Google Scholar
• Doi TS, Marino MW, Takahashi T, et al. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci USA 1999; 96:2994–2999.
  CAS PubMed PubMed Central Google Scholar
• Rosenfeld ME, Prichard L, Shiojiri N, Fausto N . Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice. Am J Pathol 2000; 156:997–1007.
  Article CAS PubMed PubMed Central Google Scholar
• Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM . Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 1999; 284:321–325.
  Article CAS PubMed Google Scholar
• Tanaka M, Fuentes ME, Yamaguchi K, et al. Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice. Immunity 1999; 10:421–429.
  Article CAS PubMed Google Scholar
• Rudolph D, Yeh WC, Wakeham A, et al. Severe liver degeneration and lack of NF-κB activation in NEMO/IKKgamma-deficient mice. Genes Dev 2000; 14:854–862.
  CAS PubMed PubMed Central Google Scholar
• Makris C, Godfrey VL, Krahn-Senftleben G, et al. Female mice heterozygous for IKK γ/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell 2000; 5:969–979.
  Article CAS PubMed Google Scholar
• Luedde T, Assmus U, Wustefeld T, et al. Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J Clin Invest 2005; 115:849–859.
  Article CAS PubMed PubMed Central Google Scholar
• Maeda S, Chang L, Li ZW, Luo JL, Leffert H, Karin M . IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα. Immunity 2003; 19:725–737.
  Article CAS PubMed Google Scholar
• Luedde T, Heinrichsdorff J, de Lorenzi R, De Vos R, Roskams T, Pasparakis M . IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver. Proc Natl Acad Sci USA 2008; 105:9733–9738.
  Article CAS PubMed PubMed Central Google Scholar
• Luedde T, Beraza N, Kotsikoris V, et al. Deletion of NEMO/IKKγ in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 2007; 11:119–132.
  Article CAS PubMed Google Scholar
• Greten FR, Eckmann L, Greten TF, et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118:285–296.
  Article CAS PubMed Google Scholar
• Verna L, Whysner J, Williams GM . N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther 1996; 71:57–81.
  Article CAS PubMed Google Scholar
• Lai DY, Arcos JC . Minireview: dialkylnitrosamine bioactivation and carcinogenesis. Life Sci 1980; 27:2149–2165.
  Article CAS PubMed Google Scholar
• Magee PN, Barnes JM . Carcinogenic nitroso compounds. Adv Cancer Res 1967; 10:163–246.
  Article CAS PubMed Google Scholar
• Fausto N . Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease. Semin Liver Dis 1999; 19:243–252.
  Article CAS PubMed Google Scholar
• Maeda S, Kamata H, Luo JL, Leffert H, Karin M . IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005; 121:977–990.
  Article CAS PubMed Google Scholar
• Luo JL, Kamata H, Karin M . IKK/NF-κB signaling: balancing life and death--a new approach to cancer therapy. J Clin Invest 2005; 115:2625–2632.
  Article CAS PubMed PubMed Central Google Scholar
• Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M . Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005; 120:649–661.
  Article CAS PubMed Google Scholar
• Pham CG, Bubici C, Zazzeroni F, et al. Ferritin heavy chain upregulation by NF-κB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 2004; 119:529–542.
  Article CAS PubMed Google Scholar
• Sakurai T, Maeda S, Chang L, Karin M . Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc Natl Acad Sci USA 2006; 103:10544–10551.
  Article CAS PubMed PubMed Central Google Scholar
• Pikarsky E, Porat RM, Stein I, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431:461–466.
  Article CAS PubMed Google Scholar
• Mauad TH, van Nieuwkerk CM, Dingemans KP, et al. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol 1994; 145:1237–1245.
  CAS PubMed PubMed Central Google Scholar
• Haybaeck J, Zeller N, Wolf MJ, et al. A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell 2009; 16:295–308.
  Article CAS PubMed PubMed Central Google Scholar
• Maeda S, Hikiba Y, Sakamoto K, et al. IκB kinasebeta/nuclear factor-κB activation controls the development of liver metastasis by way of interleukin-6 expression. Hepatology 2009; 50:1851–1860.
  Article CAS PubMed Google Scholar
• Sakurai T, He G, Matsuzawa A, et al. Hepatocyte necrosis induced by oxidative stress and IL-1 α release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 2008; 14:156–165.
  Article CAS PubMed PubMed Central Google Scholar
• Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317:121–124.
  Article CAS PubMed Google Scholar
• Jilka RL, Hangoc G, Girasole G, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992; 257:88–91.
  Article CAS PubMed Google Scholar
• Ershler WB, Keller ET . Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000; 51:245–270.
  Article CAS PubMed Google Scholar
• Tilg H, Wilmer A, Vogel W, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103:264–274.
  Article CAS PubMed Google Scholar
• Trikha M, Corringham R, Klein B, Rossi JF . Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. Clin Cancer Res 2003; 9:4653–4665.
  CAS PubMed PubMed Central Google Scholar
• Nakagawa H, Maeda S, Yoshida H, et al. Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. Int J Cancer 2009; 125:2264–2269.
  Article CAS PubMed Google Scholar
• Wong VW, Yu J, Cheng AS, et al. High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int J Cancer 2009; 124:2766–2770.
  Article CAS PubMed Google Scholar
• Wegenka UM, Buschmann J, Lutticken C, Heinrich PC, Horn F . Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol 1993; 13:276–288.
  Article CAS PubMed PubMed Central Google Scholar
• Zhong Z, Wen Z, Darnell JE Jr . Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994; 264:95–98.
  Article CAS PubMed Google Scholar
• Takeda K, Akira S . STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev 2000; 11:199–207.
  Article CAS PubMed Google Scholar
• Hirano T, Ishihara K, Hibi M . Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000; 19:2548–2556.
  Article CAS PubMed Google Scholar
• Yoshimura A, Naka T, Kubo M . SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007; 7:454–465.
  Article CAS PubMed Google Scholar
• Wen Z, Zhong Z, Darnell JE Jr . Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995; 82:241–250.
  Article CAS PubMed Google Scholar
• Yuan ZL, Guan YJ, Chatterjee D, Chin YE . Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 2005; 307:269–273.
  Article CAS PubMed Google Scholar
• Kubo M, Hanada T, Yoshimura A . Suppressors of cytokine signaling and immunity. Nat Immunol 2003; 4:1169–1176.
  Article CAS PubMed Google Scholar
• Al Zaid Siddiquee K, Turkson J . STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res 2008; 18:254–267.
  Article CAS PubMed Google Scholar
• He G, Yu GY, Temkin V, et al. Hepatocyte IKKβ/NF-κB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell 2010; 17:286–297.
  Article CAS PubMed PubMed Central Google Scholar
• Calvisi DF, Ladu S, Gorden A, et al. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology 2006; 130:1117–1128.
  Article CAS PubMed Google Scholar
• Rebouissou S, Amessou M, Couchy G, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2009; 457:200–204.
  Article CAS PubMed Google Scholar
• El-Serag HB, Rudolph KL . Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132:2557–2576.
  Article CAS PubMed Google Scholar
• Parekh S, Anania FA . Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology 2007; 132:2191–2207.
  Article CAS PubMed Google Scholar
• Wang T, Weinman SA . Causes and consequences of mitochondrial reactive oxygen species generation in hepatitis C. J Gastroenterol Hepatol 2006; 21 Suppl 3:S34–S37.
  Article CAS PubMed Google Scholar
• Takeda K, Noguchi K, Shi W, et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 1997; 94:3801–3804.
  Article CAS PubMed PubMed Central Google Scholar
• Raz R, Lee CK, Cannizzaro LA, d'Eustachio P, Levy DE . Essential role of STAT3 for embryonic stem cell pluripotency. Proc Natl Acad Sci USA 1999; 96:2846–2851.
  Article CAS PubMed PubMed Central Google Scholar
• Matsuda T, Nakamura T, Nakao K, et al. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J 1999; 18:4261–4269.
  Article CAS PubMed PubMed Central Google Scholar
• Levy DE, Lee CK . What does Stat3 do? J Clin Invest 2002; 109:1143–1148.
  Article CAS PubMed PubMed Central Google Scholar
• Chan KS, Sano S, Kiguchi K, et al. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest 2004; 114:720–728.
  Article CAS PubMed PubMed Central Google Scholar
• Bollrath J, Phesse TJ, von Burstin VA, et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 2009; 15:91–102.
  Article CAS PubMed Google Scholar
• Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 2009; 15:103–113.
  Article CAS PubMed PubMed Central Google Scholar
• Inghirami G, Chiarle R, Simmons WJ, Piva R, Schlessinger K, Levy DE . New and old functions of STAT3: a pivotal target for individualized treatment of cancer. Cell Cycle 2005; 4:1131–1133.
  Article CAS PubMed Google Scholar
• Chiarle R, Simmons WJ, Cai H, et al. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat Med 2005; 11:623–629.
  Article CAS PubMed Google Scholar
• Yue P, Turkson J . Targeting STAT3 in cancer: how successful are we? Expert Opin Investig Drugs 2009; 18:45–56.
  Article CAS PubMed PubMed Central Google Scholar
• Fletcher S, Drewry JA, Shahani VM, Page BD, Gunning PT . Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein. Biochem Cell Biol 2009; 87:825–833.
  Article CAS PubMed Google Scholar
• Siddiquee K, Zhang S, Guida WC, et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci USA 2007; 104:7391–7396.
  Article CAS PubMed PubMed Central Google Scholar
• Lin L, Amin R, Gallicano GI, et al. The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-β signaling. Oncogene 2009; 28:961–972.
  Article CAS PubMed PubMed Central Google Scholar
• Meydan N, Grunberger T, Dadi H, et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 1996; 379:645–648.
  Article CAS PubMed Google Scholar
• Yang J, Chatterjee-Kishore M, Staugaitis SM, et al. Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. Cancer Res 2005; 65:939–947.
  CAS PubMed Google Scholar
• Li WC, Ye SL, Sun RX, et al. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Clin Cancer Res 2006; 12:7140–7148.
  Article CAS PubMed Google Scholar
• Hedvat M, Huszar D, Herrmann A, et al. The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors. Cancer Cell 2009; 16:487–497.
  Article CAS PubMed PubMed Central Google Scholar
• Grivennikov SI, Karin M . Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 2010; 21:11–19.
  Article CAS PubMed Google Scholar
• Atkinson GP, Nozell SE, Benveniste ET . NF-κB and STAT3 signaling in glioma: targets for future therapies. Expert Rev Neurother 2010; 10:575–586.
  Article CAS PubMed Google Scholar
• Bollrath J, Greten FR . IKK/NF-κB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep 2009; 10:1314–1319.
  Article CAS PubMed PubMed Central Google Scholar
• Valentino L, Pierre J . JAK/STAT signal transduction: regulators and implication in hematological malignancies. Biochem Pharmacol 2006; 71:713–721.
  Article CAS PubMed Google Scholar
• Hsu L-C, Enzler T, Seita J, et al. IL-1β-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKβ. Nat Immunol 2010; in press.
• Lee H, Herrmann A, Deng JH, et al. Persistently activated Stat3 maintains constitutive NF-κB activity in tumors. Cancer Cell 2009; 15:283–293.
  Article CAS PubMed PubMed Central Google Scholar
• Chen L, Fischle W, Verdin E, Greene WC . Duration of nuclear NF-κB action regulated by reversible acetylation. Science 2001; 293:1653–1657.
  Article CAS Google Scholar
• Bruix J, Sherman M . Management of hepatocellular carcinoma. Hepatology 2005; 42:1208–1236.
  Article PubMed Google Scholar
• Park EJ, Lee JH, Yu GY, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010; 140:197–208.
  Article CAS PubMed PubMed Central Google Scholar